139 related articles for article (PubMed ID: 37590371)
1. Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals.
Woods JJ; Cosby AG; Wacker JN; Aguirre Quintana LM; Peterson A; Minasian SG; Abergel RJ
Inorg Chem; 2023 Dec; 62(50):20721-20732. PubMed ID: 37590371
[TBL] [Abstract][Full Text] [Related]
2. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.
Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW
Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491
[TBL] [Abstract][Full Text] [Related]
3. Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.
Ma MT; Meszaros LK; Paterson BM; Berry DJ; Cooper MS; Ma Y; Hider RC; Blower PJ
Dalton Trans; 2015 Mar; 44(11):4884-900. PubMed ID: 25351250
[TBL] [Abstract][Full Text] [Related]
4. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
[TBL] [Abstract][Full Text] [Related]
5. Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms.
Captain I; Deblonde GJ; Rupert PB; An DD; Illy MC; Rostan E; Ralston CY; Strong RK; Abergel RJ
Inorg Chem; 2016 Nov; 55(22):11930-11936. PubMed ID: 27802058
[TBL] [Abstract][Full Text] [Related]
6. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
Zhou X; Dong L; Shen L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Candidate Theranostics for
Abou DS; Longtine M; Fears A; Benabdallah N; Unnerstall R; Johnston H; Shim K; Hasson A; Zhang H; Ulmert D; Mangin F; Ozen S; Raibaut L; Brandès S; Meyer M; Chambron JC; Tatum DS; Magda D; Wahl RL; Thorek DLJ
J Nucl Med; 2023 Jul; 64(7):1062-1068. PubMed ID: 37142300
[No Abstract] [Full Text] [Related]
8. Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for
Woods JJ; Unnerstall R; Hasson A; Abou DS; Radchenko V; Thorek DLJ; Wilson JJ
Inorg Chem; 2022 Feb; 61(7):3337-3350. PubMed ID: 35137587
[TBL] [Abstract][Full Text] [Related]
9. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
[TBL] [Abstract][Full Text] [Related]
12. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy.
Deblonde GJ; Lohrey TD; Booth CH; Carter KP; Parker BF; Larsen Å; Smeets R; Ryan OB; Cuthbertson AS; Abergel RJ
Inorg Chem; 2018 Nov; 57(22):14337-14346. PubMed ID: 30372069
[TBL] [Abstract][Full Text] [Related]
13. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
Seibold U; Wängler B; Wängler C
ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
[TBL] [Abstract][Full Text] [Related]
14. Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.
Cusnir R; Imberti C; Hider RC; Blower PJ; Ma MT
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075350
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
[TBL] [Abstract][Full Text] [Related]
16. Predicting the Thermodynamic Stability of Zirconium Radiotracers.
Holland JP
Inorg Chem; 2020 Feb; 59(3):2070-2082. PubMed ID: 31940188
[TBL] [Abstract][Full Text] [Related]
17. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
[TBL] [Abstract][Full Text] [Related]
18. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
Guérard F; Lee YS; Brechbiel MW
Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
[TBL] [Abstract][Full Text] [Related]
19. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.
Cai Z; Anderson CJ
J Labelled Comp Radiopharm; 2014 Apr; 57(4):224-30. PubMed ID: 24347474
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications.
Albanese V; Roccatello C; Pacifico S; Guerrini R; Preti D; Gentili S; Tegoni M; Remelli M; Bellotti D; Amico J; Gorgoni G; Cazzola E
EJNMMI Radiopharm Chem; 2024 May; 9(1):38. PubMed ID: 38705946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
